A new sudy revealed that protective B cell responses to the SARS-CoV-2 spike protein remain stable and continue to evolve over a 5-month period post-infection. This is contrary to the previous hypotheses made by some researchers.
For the study, the researchers examined B cells and more than 1,000 different monoclonal antibodies from eight patients with Covid-19.
Their findings suggested that B cells protect from Covid-19 months after the infection. However, a large proportion of the neutralizing antibodies generated from these long-lasting B cells did not efficiently recognize various emerging SARS-CoV-2 variants from Brazil and South Africa.
The authors believe that their study will help other scientists to design future Covid-19 vaccines that work to prevent viral evolution. The vaccines should also stimulate better neutralizing antibody and B cell responses against emerging SARS-CoV-2 variants.
In the study, Mrunal Sakharkar and the team profiled spike protein-specific B cell and antibody responses in eight patients with mild and severe Covid-19 over five months.
They found a significant decline in neutralizing antibody levels in the blood over time. However, levels of spike protein-specific memory B cells remained stable or even increased during the same time frame.
Over the course of 120 days, monoclonal antibodies isolated from these B cells underwent increased somatic hypermutation, binding affinity, and neutralization potency - all signs of persistent B cell activity.
Notably, a large proportion of the neutralizing antibody response did not efficiently recognize emerging SARS-CoV-2 variants from Brazil and South Africa. These mutations harbour amino acid positions 417 and 484 of the spike protein.
The authors suggested careful monitoring of circulating SARS-CoV-2 variants so as to determine how these mutations impact vaccine-induced immunity.
The findings of the study were published in the journal American Association for Advancement of Science (AAAS).
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.